Urethral pain syndrome: fact or fiction - an update

被引:7
作者
Dreger, N. M. [1 ]
Degener, S. [1 ]
Roth, S. [1 ]
Brandt, A. S. [1 ]
Lazica, D. A. [2 ]
机构
[1] Univ Witten Herdecke, HELIOS Klinikum Wuppertal, Klin Urol & Kinderurol, Lehrstuhl Urol,ZFKM, D-42283 Wuppertal, Germany
[2] Klinikum Bremen Mitte, Urol Klin, Bremen, Germany
来源
UROLOGE | 2015年 / 54卷 / 09期
关键词
Urethra; Lower urinary dysfunctional; epithelium; Chronic pelvic pain syndrome; Hypoestrogenism; Trigonal metaplasia; URINARY-TRACT-INFECTIONS; CHRONIC PELVIC PAIN; INTERSTITIAL CYSTITIS; FEMALE-PATIENTS; CLINICAL SYMPTOMS; GENERAL-PRACTICE; YAG LASER; FREQUENCY; WOMEN; PROSTATITIS;
D O I
10.1007/s00120-015-3926-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Urethral pain syndrome is a symptom complex including dysuria, urinary urgency and frequency, nocturia and persistent or intermittent urethral and/or pelvic pain in the absence of proven infection. These symptoms overlap with several other conditions, such as interstitial cystitis bladder pain syndrome and overactive bladder. Urethral pain syndrome may occur in men but is more frequent in women. Diagnostic. The exact etiology is unknown but infectious and psychogenic factors, urethral spasms, early interstitial cystitis, hypoestrogenism, squamous metaplasia as well as gynecological risk factors are discussed. These aspects should be ruled out or confirmed in the diagnostic approach. Despite the assumption of a multifactorial etiology, pathophysiologically there is a common pathway: dysfunctional epithelium of the urethra becomes leaky which leads to bacterial and abacterial inflammation and ends in fibrosis due to the chronic impairment. Therapy. The therapeutic approach should be multimodal using a trial and error concept: general treatment includes analgesia, antibiotics, alpha receptor blockers and muscle relaxants, antimuscarinic therapy, topical vaginal estrogen, psychological support and physical therapy. In cases of nonresponding patients intravesical and/or surgical therapy should be considered. The aim of this review is to summarize the preliminary findings on urethral pain syndrome and to elucidate the diagnostic and therapeutic options.
引用
收藏
页码:1248 / +
页数:7
相关论文
共 46 条
[21]   THE FEMALE URETHRAL SYNDROME - EXTERNAL SPHINCTER SPASM AS ETIOLOGY [J].
KAPLAN, WE ;
FIRLIT, CF ;
SCHOENBERG, HW .
JOURNAL OF UROLOGY, 1980, 124 (01) :48-49
[22]   Urethral pain syndrome and its management [J].
Kaur, Hervinder ;
Arunkalaivanan, Angamuthu S. .
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2007, 62 (05) :348-351
[23]  
Krause Megan, 2009, J Pelvic Med Surg, V15, P105
[24]  
LIPSKY H, 1977, EUR UROL, V3, P202
[25]  
Liu Lian, 2003, J Tradit Chin Med, V23, P284
[26]  
MASKELL R, 1979, LANCET, V1, P1058
[27]   UROTHELIAL LEUKOPLAKIA - NEW ASPECTS OF ETIOLOGY AND THERAPY [J].
MUELLER, SC ;
THUEROFF, JW ;
RUMPELT, HJ .
JOURNAL OF UROLOGY, 1987, 137 (05) :979-983
[28]   Pentosan Polysulfate Sodium for Treatment of Interstitial Cystitis/Bladder Pain Syndrome: Insights from a Randomized, Double-Blind, Placebo Controlled Study [J].
Nickel, J. Curtis ;
Herschorn, Sender ;
Whitmore, Kristene E. ;
Forrest, John B. ;
Hu, Peter ;
Friedman, Andrew J. ;
Baseman, Alan S. .
JOURNAL OF UROLOGY, 2015, 193 (03) :857-862
[29]   The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain [J].
Parsons, C. Lowell .
BJU INTERNATIONAL, 2011, 107 (03) :370-375
[30]   TREATMENT OF INTERSTITIAL CYSTITIS WITH INTRAVESICAL HEPARIN [J].
PARSONS, CL ;
HOUSLEY, T ;
SCHMIDT, JD ;
LEBOW, D .
BRITISH JOURNAL OF UROLOGY, 1994, 73 (05) :504-507